Anxiety and Related Sleep Disorders - Belgium

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$163.60m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.49%, resulting in a market volume of US$167.70m by 2029.
In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
In relation to total population figures, per person revenues of US$216.80 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

Pharmaceutical sales and consumption of anxiolytics
Pharmaceutical sales and consumption hypnotics and sedatives

Non-mental health related sleep disorders
Any other anxiety medications
Psychotherapy

The Anxiety and Related Sleep Disorders market in Belgium is experiencing significant growth due to several factors.

Customer preferences: Customers in Belgium are increasingly seeking solutions for anxiety and related sleep disorders. This is driven by a growing awareness of the importance of mental health and the impact it has on overall well-being. Additionally, the fast-paced and stressful nature of modern life has contributed to an increase in anxiety and sleep disorders among the population. As a result, there is a strong demand for products and services that can help alleviate these conditions.

Trends in the market: One of the key trends in the Anxiety and Related Sleep Disorders market in Belgium is the rising popularity of natural and holistic remedies. Customers are increasingly looking for products that are derived from natural ingredients and have minimal side effects. This trend is driven by a desire to avoid the potential risks and dependencies associated with pharmaceutical solutions. As a result, there has been a surge in the availability and variety of natural remedies such as herbal supplements, aromatherapy, and mindfulness practices.Another trend in the market is the increasing use of technology to address anxiety and sleep disorders. Mobile applications and wearable devices that track sleep patterns and provide guided meditation or relaxation exercises have gained popularity among customers. These technological solutions offer convenience and accessibility, allowing individuals to manage their conditions from the comfort of their own homes.

Local special circumstances: Belgium has a well-developed healthcare system that prioritizes mental health. There is a strong network of healthcare professionals, including psychiatrists and psychologists, who specialize in anxiety and sleep disorders. This has created a supportive environment for individuals seeking treatment and has contributed to the growth of the market.

Underlying macroeconomic factors: The growing Anxiety and Related Sleep Disorders market in Belgium is also influenced by macroeconomic factors. Belgium has a stable economy with a high standard of living, which allows individuals to invest in their well-being. Additionally, the government provides support for mental health services through public healthcare initiatives and insurance coverage. This makes treatment more accessible and affordable for individuals, further driving the demand for products and services in the market.In conclusion, the Anxiety and Related Sleep Disorders market in Belgium is experiencing significant growth due to increasing customer preferences for natural and holistic remedies, the use of technology to address these conditions, the supportive healthcare system, and the stable macroeconomic factors in the country.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.